| Dr David Arnot Rasch, PHD | |
|
2555 Park Blvd, Palo Alto, CA 94306-1924 | |
| (650) 799-1569 | |
| Not Available |
| Full Name | Dr David Arnot Rasch |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Counseling |
| Location | 2555 Park Blvd, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205053972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | PSY13027 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Arnot Rasch, PHD 27200 Prado Del Sol, Carmel, CA 93923-9526 Ph: (650) 799-1569 | Dr David Arnot Rasch, PHD 2555 Park Blvd, Palo Alto, CA 94306-1924 Ph: (650) 799-1569 |
News Archive
News outlets report on the predictions offered by the Medicare trustees, and examine the assumptions behind them as well as the political landscape.
U.S. Consumer Product Safety Commission Chairman Elliot F. Kaye and U.S. Rep. Debbie Wasserman Schultz (FL-23) announced today the awardees of a first-of-its-kind grant program aimed at preventing pool and spa drownings and drain entrapments. Five local governments will receive more than $780,000 in Pool Safely Grant Program (PSGP) funds.
Patients with severe asthma who use an internet-supported strategy and daily monitoring of exhaled nitric oxide were able to control their asthma with lower overall dosing of oral corticosteroids than patients who underwent usual care, according to research from the Netherlands.
Cardiome Pharma Corp. today announced that its co-development partner, Astellas Pharma US., Inc., has suspended patient enrollment in the ACT 5 study of KYNAPIDTM (vernakalant hydrochloride) Injection following a single unexpected serious adverse event of cardiogenic shock experienced by a patient with atrial fibrillation who received KYNAPID.
Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent.
› Verified 2 days ago
Dr. Zoi Dorit Eliou, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 665 Lytton Ave # 4, Palo Alto, CA 94301 Phone: 650-704-9424 | |
Dr. Zahra Murtaza, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-617-3829 | |
Diana Naranjo, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 401 Quarry Rd, Child And Adolescent Psychiatry, Palo Alto, CA 94304 Phone: 650-723-5511 Fax: 650-724-7389 | |
Susan Spinrad, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 560 Oxford Ave, Suite 3b, Palo Alto, CA 94306 Phone: 650-599-5825 | |
Dr. Lital Koropitzer, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 825 El Camino Real, Palo Alto, CA 94301 Phone: 650-223-6400 | |
Barbara M Sourkes, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Ferol F. Larsen, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 555 Middlefield Rd, Palo Alto, CA 94301 Phone: 650-326-6896 Fax: 650-326-6896 |